Grantham, Mayo, Van Otterloo & Co. LLC
Institutional investor · Portfolio as of Q4 2018
Top Holdings524 positions
Apple Inc. | 3.6M | $569.7M | 4.5% | $37.39 | 0.00% | 1 qtr | First report 0 |
Microsoft Corp. | 5.2M | $530.3M | 4.2% | $94.43 | 0.00% | 1 qtr | First report 0 |
Oracle Corp. | 10.5M | $472.6M | 3.8% | $40.29 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc. | 440,010 | $455.7M | 3.6% | $51.29 | 0.00% | 1 qtr | First report 0 |
3M CO | 1.9M | $355.3M | 2.8% | $122.28 | 0.00% | 1 qtr | First report 0 |
Medtronic PLC | 3.6M | $329.9M | 2.6% | $73.07 | 0.00% | 1 qtr | First report 0 |
Johnson & Johnson | 2.4M | $315.7M | 2.5% | $104.33 | 0.00% | 1 qtr | First report 0 |
Costco Wholesale Corporation | 1.5M | $297.1M | 2.4% | $183.62 | 0.00% | 1 qtr | First report 0 |
UnitedHealth Group Inc. | 1.2M | $294.1M | 2.3% | $217.84 | 0.00% | 1 qtr | First report 0 |
WELLS FARGO CO NEW | 6.1M | $282.8M | 2.3% | $37.34 | 0.00% | 1 qtr | First report 0 |
Accenture PLC | 1.9M | $274M | 2.2% | $124.99 | 0.00% | 1 qtr | First report 0 |
Merck & Co., Inc | 3.5M | $271.2M | 2.2% | $57.51 | 0.00% | 1 qtr | First report 0 |
US BANCORP DEL | 5.9M | $270.5M | 2.2% | $33.31 | 0.00% | 1 qtr | First report 0 |
AMERICAN EXPRESS CO | 2.8M | $262.4M | 2.1% | $86.06 | 0.00% | 1 qtr | First report 0 |
Texas Instruments Inc. | 2.6M | $245.6M | 2.0% | $76.19 | 0.00% | 1 qtr | First report 0 |
ANTHEM INC | 927,937 | $243.7M | 1.9% | $235.91 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc. | 227,472 | $237.7M | 1.9% | $51.76 | 0.00% | 1 qtr | First report 0 |
| 2.1M | $223.9M | 1.8% | — | — | 1 qtr | First report 0 | |
The TJX Companies Inc. | 4.9M | $218.5M | 1.7% | $40.34 | 0.00% | 1 qtr | First report 0 |
COGNIZANT TECHNOLOGY SOLUTIO | 3.3M | $211.7M | 1.7% | $56.23 | 0.00% | 1 qtr | First report 0 |
Grantham, Mayo, Van Otterloo & Co. LLC manages $12.5B across 524 positions as of Q4 2018. Top holdings: AAPL (4.5%), MSFT (4.2%), ORCL (3.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 5/5.0.
First quarter we have for this fund: 524 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $12.5B across 524 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR